These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7513681)

  • 1. A cytotoxic human hybridoma monoclonal antibody (TrJ6) defining an epitope expressed by HLA-DQ4 and -DQ5.
    Ge J; Hannestad K
    Hum Immunol; 1994 Feb; 39(2):106-12. PubMed ID: 7513681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human monoclonal antibody reacting against HLA-DQ1-, DQ4-, and a subset of DQ7-bearing cells.
    Sánchez B; de la Calle O; Yélamos J; Aguilera I; Sánchez F; Dessi V; Siervo S; García-Lozano JR; Melero J; Magariño R
    Hum Immunol; 1993 Feb; 36(2):81-90. PubMed ID: 7681815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two HLA-DQ-specific human-human hybridoma antibodies (TrG6;TrC5) define epitopes also expressed by a transcomplementing hybrid DQ molecule (DQw7 alpha/DQw4 beta).
    Kolstad A; Johansen B; Hannestad K
    Hum Immunol; 1989 Jan; 24(1):15-29. PubMed ID: 2464569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a murine monoclonal antibody recognizing HLA-DQ5(1), DQ6(1) and DQ4 antigens.
    Walsh S; Cayrol C; Clement D; Mouynet P; Alam A; Tkaczuk J; Cambon-Thomsen A
    Tissue Antigens; 1993 Mar; 41(3):165-8. PubMed ID: 7686309
    [No Abstract]   [Full Text] [Related]  

  • 5. A human monoclonal hybridoma antibody (TrJ1) specific for HLA-DQ2.
    Ge J; Bartnes K; Hannestad K
    Tissue Antigens; 1993 Feb; 41(2):81-5. PubMed ID: 8386401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of an epitope defined by a human hybridoma antibody (TrD3): a new HLA-B supertype associated with a subset of HLA-Bw6.
    Kolstad A; Toubert A; Weyl D; Jun G; Hannestad K
    Hum Immunol; 1992 Jun; 34(2):77-84. PubMed ID: 1385373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cytotoxic human hybridoma monoclonal antibody (TrJ5) specific for HLA-B38(16) and -B39(16).
    Ge J; Hannestad K
    Hum Immunol; 1993 Mar; 36(3):168-71. PubMed ID: 7686545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel HLA-A determinant recognized by a cytotoxic human hybridoma IgG1 monoclonal antibody (TrJ14).
    Ge J; Bratlie A; Hannestad K
    Tissue Antigens; 1994 Nov; 44(5):306-10. PubMed ID: 7533338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human-human hybridoma antibody (TrB12) defining subgroups of HLA-DQw1 and -DQw3.
    Kolstad A; Hansen T; Hannestad K
    Hum Immunol; 1987 Nov; 20(3):219-31. PubMed ID: 2830209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human-human hybridoma (Tr7E2) producing cytotoxic antibody to HLA-DQw1.
    Hansen T; Kolstad A; Mathisen G; Hannestad K
    Hum Immunol; 1987 Dec; 20(4):307-20. PubMed ID: 2449413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytotoxic HLA-DQ3 reactive human hybridoma antibody 4166 that may distinguish DQ7 + 8 from DQ9.
    Viken HD; Thoresen AB; Thorsby E; Hansen T
    Hum Immunol; 1995 Apr; 42(4):281-8. PubMed ID: 7558911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human hybridoma monoclonal antibody (TrJ11) recognizing a new HLA-DR epitope shared by DR4, DR8, DR11, and DRB1*1303.
    Ge J; Bratlie A; Hannestad K
    Hum Immunol; 1995 Jan; 42(1):27-34. PubMed ID: 7538497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis patients have a high frequency of an HLA-DQ beta epitope defined by a human-human hybridoma antibody.
    Kolstad A; Hannestad K; Vandvik B; Vartdal F
    Tissue Antigens; 1989 May; 33(5):546-9. PubMed ID: 2477915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytotoxic monoclonal human hybridoma antibody (TrJ3) against HLA-B44(12) and -B45(12).
    Ge J; Bratlie A; Hannestad K
    Tissue Antigens; 1992 May; 39(5):258-61. PubMed ID: 1384167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and epitope mapping of four HLA class II reactive mouse monoclonal antibodies using transfected L cells and human cells transfected with mutants of DQB1*0302.
    Viken HD; Thorsby E; Gaudernack G
    Tissue Antigens; 1995 Apr; 45(4):250-7. PubMed ID: 7638861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an HLA-DQ2-specific monoclonal antibody. Influence of amino acid substitutions in DQ beta 1*0202.
    Viken HD; Paulsen G; Sollid LM; Lundin KE; Tjønnfjord GE; Thorsby E; Gaudernack G
    Hum Immunol; 1995 Apr; 42(4):319-27. PubMed ID: 7558917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Childhood Diabetes in Finland Study Group.
    Parkkonen P; Hyöty H; Ilonen J; Reijonen H; Ylä-Herttuala S; Leinikki P
    Clin Exp Immunol; 1994 Feb; 95(2):287-93. PubMed ID: 7508347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of two human hybridomas secreting antibodies to HLA-DRw11 and--DRw8+w12 specificities.
    Pistillo MP; Mazzoleni O; Kun L; Falco M; Tazzari PL; Ferrara GB
    Hum Immunol; 1991 Jun; 31(2):86-93. PubMed ID: 1712351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cytotoxic human-human hybridoma antibodies to HLA: TrAH10 (anti A3.1) and TrAG2 (anti B7, Bw42).
    Hansen T; Bratlie A; Johansen B; Hannestad K
    Tissue Antigens; 1989 May; 33(5):520-30. PubMed ID: 2552610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cytotoxic human-human hybridoma antibody (TrH6) specific for HLA-DRw52.
    Kolstad A; Hansen T; Hannestad K
    Tissue Antigens; 1988 Feb; 31(2):90-7. PubMed ID: 2836964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.